254 related articles for article (PubMed ID: 8557344)
1. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
Koprowski H; Levine MM; Anderson RJ; Losonsky G; Pizza M; Barry EM
Infect Immun; 2000 Sep; 68(9):4884-92. PubMed ID: 10948101
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
5. Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
Kotloff KL; Noriega F; Losonsky GA; Sztein MB; Wasserman SS; Nataro JP; Levine MM
Infect Immun; 1996 Nov; 64(11):4542-8. PubMed ID: 8890204
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
7. Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
Noriega FR; Losonsky G; Lauderbaugh C; Liao FM; Wang JY; Levine MM
Infect Immun; 1996 Aug; 64(8):3055-61. PubMed ID: 8757833
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
Noriega FR; Wang JY; Losonsky G; Maneval DR; Hone DM; Levine MM
Infect Immun; 1994 Nov; 62(11):5168-72. PubMed ID: 7927802
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains.
Alexander WA; Hartman AB; Oaks EV; Venkatesan MM
Vaccine; 1996 Aug; 14(11):1053-61. PubMed ID: 8879102
[TBL] [Abstract][Full Text] [Related]
10. Regulated Delayed
Su H; Liu Q; Wang S; Curtiss R; Kong Q
Theranostics; 2019; 9(12):3565-3579. PubMed ID: 31281498
[No Abstract] [Full Text] [Related]
11. Construction of a novel Shigella live-vector strain co-expressing CS3 and LTB/STm of enterotoxigenic E.coli.
Zheng JP; Zhang ZS; Li SQ; Liu XX; Yuan SL; Wang P; Zhan DW; Wang LC; Huang CF
World J Gastroenterol; 2005 Jun; 11(22):3411-8. PubMed ID: 15948247
[TBL] [Abstract][Full Text] [Related]
12. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.
Hartman AB; Van de Verg LL; Collins HH; Tang DB; Bendiuk NO; Taylor DN; Powell CJ
Infect Immun; 1994 Feb; 62(2):412-20. PubMed ID: 7507892
[TBL] [Abstract][Full Text] [Related]
13. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
14. Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.
Barry EM; Altboum Z; Losonsky G; Levine MM
Vaccine; 2003 Jan; 21(5-6):333-40. PubMed ID: 12531629
[TBL] [Abstract][Full Text] [Related]
15. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
Kärnell A; Cam PD; Verma N; Lindberg AA
Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli.
Ranallo RT; Fonseka CP; Cassels F; Srinivasan J; Venkatesan MM
Infect Immun; 2005 Jan; 73(1):258-67. PubMed ID: 15618162
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous expression of CS3 colonization factor antigen and LT-B/ST fusion enterotoxin antigen of enterotoxigenic Escherichia coli by attenuated Shigella flexneri 2a].
Liu TT; Li SQ; Zhang ZS; Zheng JP; Liu XL; Luo G; Huang CF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):49-54. PubMed ID: 12518227
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
[TBL] [Abstract][Full Text] [Related]
19. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.
Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR
Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734
[TBL] [Abstract][Full Text] [Related]
20. Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates.
Ranallo RT; Fonseka S; Boren TL; Bedford LA; Kaminski RW; Thakkar S; Venkatesan MM
Vaccine; 2012 Jul; 30(34):5159-71. PubMed ID: 22658966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
